System Immunogenetics of West Nile Virus Infection Adaptive Immunity

$397,595U19FY2015AINIH

Univ Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Linked publications & trials

Paper 39325545 Paper 39192977 Paper 38908483 Paper 38702297 Paper 38670234 Paper 38652660 Paper 38508400 Paper 38360537 Paper 38276675 Paper 37961507 Paper 37745496 Paper 37572089 Paper 37540195 Paper 37310228 Paper 37243143 Paper 36944993 Paper 36939421 Paper 36851745 Paper 36741372 Paper 36574452 Paper 36563691 Paper 36423831 Paper 36336910 Paper 36198789 Paper 35932641 Paper 35896528 Paper 35862771 Paper 35834486 Paper 35764696 Paper 35688478 Paper 35194609 Paper 35191378 Paper 35112666 Paper 34958350 Paper 34931189 Paper 34777354 Paper 34610856 Paper 34523968 Paper 34372702 Paper 34342578 Paper 34159335 Paper 33893179 Paper 33691138 Paper 33657418 Paper 33640018 Paper 33627703 Paper 33561864 Paper 33513210 Paper 33488611 Paper 33067325 Paper 33060595 Paper 33010815 Paper 32995791 Paper 32995766 Paper 32979938 Paper 32938761 Paper 32854108 Paper 32852103 Paper 32792628 Paper 32756549 Paper 32526206 Paper 32511335 Paper 32434946 Paper 32434945 Paper 32348764 Paper 32289263 Paper 32284379 Paper 32272626 Paper 32160149 Paper 31980485 Paper 31621854 Paper 31540729 Paper 31471108 Paper 31451733 Paper 31415679 Paper 31409781 Paper 31090472 Paper 31036644 Paper 30974083 Paper 30952515 Paper 30858237 Paper 30796192 Paper 30658390 Paper 30457675 Paper 30371803 Paper 30342892 Paper 30301856 Paper 30297339 Paper 30151711 Paper 29982912 Paper 29976657 Paper 29947965 Paper 29924460 Paper 29746837 Paper 29559569 Paper 29540599 Paper 29499768 Paper 29408905 Paper 29400709 Paper 29339515

Abstract

PROJECT SUMMARY (See instructions): West Nile virus (WNV) is a neurotropic virus well documented to require innate immunity, humoral immunity, as well as T-cell mediated immunity in order to generate effective protection and viral control. Due to the varied and complex nature of the immune responses generated in response to WNV infection, there are naturally complex and varied genetic networks involved in immunity to WNV as well, though to date, we lack a complete understanding of how host genetic diversity impacts the orchestration of immunity to virus infection. Thus, the goal of Project 4 is to use a systems immunology approach to identify candidate host genes and genetic networks that control regulation of adaptive immunity, as well as the interplay between innate and adaptive immunity, to West Nile virus infection, thereby providing us with a better understanding of how adaptive immunity to neurotropic viruses is regulated at the genetic level. In order to accomplish this goal, we plan to use the Collaborative Cross (CC) mice, a highly diverse recombinant inbred mouse panel designed to promote the identification and characterization of multiple interacting genes underlying complex phenotypes, such as host immunity to viral infection. The use of this unique genetic tool will therefore allow us to identify multiple immunoregulatory genes and genetic networks that control various aspects of WNV induced adaptive immunity, and in conjunction with Project 3, the goal of which is to identify genes regulating innate immunity to WNV, to link innate and adaptive immune networks in response to WNV. This will ultimately allow us to not only validate these targets in human systems, but also to generate more effective animal models of virus infection so that we can better simulate human diversity and make further discoveries that will allow us to create better vaccines and therapies for West Nile and other neuroinvasive viral diseases.

View original record on NIH RePORTER →